Mucin 6 (MUC6) immunostaining and tumor phenotype in breast cancers of no special type, colon adenocarcinomas, endometrioid endometrium carcinoma, serous ovarian cancers, pancreatic adenocarcinomas, and gastric cancers. Here, MUC6 is linked to neoplasm.